S S Hung|B Ardalan - JoVE Visualize

Showing results (41-50 of 62) with videos related to

Pageof 7

Sort By:

Cancer|October 1, 1994

Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreasB Ardalan, A Ucar, R Reddy, et al.

The Journal of Nutrition|August 1, 1982

Uptake, transport and distribution of DL-alpha-tocopheryl acetate compared to D-alpha-tocopherol in rainbow trout (Salmo gairdneri)S S Hung, T W Moon, J W Hilton, et al.

The Journal of Nutrition|February 1, 1987

Growth of juvenile white sturgeon (Acipenser transmontanus) fed different purified dietsS S Hung, B J Moore, C E Bordner, et al.

Cancer Research|May 1, 1980

Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracilB Ardalan, D A Cooney, H N Jayaram, et al.

Cancer Research|September 1, 1985

Pharmacokinetic and biochemical studies on acivicin in phase I clinical trialsJ P McGovren, E A Pratt, R J Belt, et al.

International Journal of Radiation Oncology, Biology, Physics|January 1, 1992

Phase I study of high dose 5-fluorouracil and high dose Leucovorin with low dose phosphonacetyl-L-aspartic acid in patients with advanced malignanciesB Ardalan, K Stridhar, R Reddy, et al.

The Journal of Nutrition|May 1, 1989

Ability of juvenile white sturgeon (Acipenser transmontanus) to utilize different carbohydrate sourcesS S Hung, F K Fynn-Aikins, P B Lutes, et al.

Cancer Research|January 1, 1981

Long-term association of N-(phosphonacetyl)-L-aspartate with boneB Ardalan, T W Kensler, H N Jayaram, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991

A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinomaB Ardalan, L Chua, E M Tian, et al.

Cancer|September 15, 1991

A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignanciesB Ardalan, K S Sridhar, P Benedetto, et al.

Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:

Pageof 7

Cancer|October 1, 1994

Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreasB Ardalan, A Ucar, R Reddy, et al.

The Journal of Nutrition|August 1, 1982

Uptake, transport and distribution of DL-alpha-tocopheryl acetate compared to D-alpha-tocopherol in rainbow trout (Salmo gairdneri)S S Hung, T W Moon, J W Hilton, et al.

The Journal of Nutrition|February 1, 1987

Growth of juvenile white sturgeon (Acipenser transmontanus) fed different purified dietsS S Hung, B J Moore, C E Bordner, et al.

Cancer Research|May 1, 1980

Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracilB Ardalan, D A Cooney, H N Jayaram, et al.

Cancer Research|September 1, 1985

Pharmacokinetic and biochemical studies on acivicin in phase I clinical trialsJ P McGovren, E A Pratt, R J Belt, et al.

International Journal of Radiation Oncology, Biology, Physics|January 1, 1992

Phase I study of high dose 5-fluorouracil and high dose Leucovorin with low dose phosphonacetyl-L-aspartic acid in patients with advanced malignanciesB Ardalan, K Stridhar, R Reddy, et al.

The Journal of Nutrition|May 1, 1989

Ability of juvenile white sturgeon (Acipenser transmontanus) to utilize different carbohydrate sourcesS S Hung, F K Fynn-Aikins, P B Lutes, et al.

Cancer Research|January 1, 1981

Long-term association of N-(phosphonacetyl)-L-aspartate with boneB Ardalan, T W Kensler, H N Jayaram, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991

A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinomaB Ardalan, L Chua, E M Tian, et al.

Cancer|September 15, 1991

A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignanciesB Ardalan, K S Sridhar, P Benedetto, et al.

Pageof 7